Structure

Physi-Chem Properties

Molecular Weight:  576.15
Volume:  538.021
LogP:  0.869
LogD:  0.192
LogS:  -2.354
# Rotatable Bonds:  10
TPSA:  226.58
# H-Bond Aceptor:  14
# H-Bond Donor:  6
# Rings:  4
# Heavy Atoms:  14

MedChem Properties

QED Drug-Likeness Score:  0.155
Synthetic Accessibility Score:  4.508
Fsp3:  0.407
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -6.476
MDCK Permeability:  3.820866913883947e-05
Pgp-inhibitor:  0.01
Pgp-substrate:  0.991
Human Intestinal Absorption (HIA):  0.527
20% Bioavailability (F20%):  0.188
30% Bioavailability (F30%):  0.993

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.263
Plasma Protein Binding (PPB):  87.46526336669922%
Volume Distribution (VD):  0.384
Pgp-substrate:  10.04910945892334%

ADMET: Metabolism

CYP1A2-inhibitor:  0.051
CYP1A2-substrate:  0.047
CYP2C19-inhibitor:  0.016
CYP2C19-substrate:  0.061
CYP2C9-inhibitor:  0.005
CYP2C9-substrate:  0.1
CYP2D6-inhibitor:  0.012
CYP2D6-substrate:  0.096
CYP3A4-inhibitor:  0.015
CYP3A4-substrate:  0.087

ADMET: Excretion

Clearance (CL):  2.0
Half-life (T1/2):  0.952

ADMET: Toxicity

hERG Blockers:  0.217
Human Hepatotoxicity (H-HT):  0.206
Drug-inuced Liver Injury (DILI):  0.947
AMES Toxicity:  0.233
Rat Oral Acute Toxicity:  0.014
Maximum Recommended Daily Dose:  0.002
Skin Sensitization:  0.022
Carcinogencity:  0.067
Eye Corrosion:  0.003
Eye Irritation:  0.016
Respiratory Toxicity:  0.005

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC57072

Natural Product ID:  NPC57072
Common Name*:   [2-[(2S,3R,4S,5S,6R)-3-Benzoyloxy-4,5-Dihydroxy-6-(Hydroxymethyl)Oxan-2-Yl]Oxy-5-Hydroxyphenyl]Methyl (1R,2R,6R)-1,2,6-Trihydroxy-5-Oxocyclohex-3-Ene-1-Carboxylate
IUPAC Name:   [2-[(2S,3R,4S,5S,6R)-3-benzoyloxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-5-hydroxyphenyl]methyl (1R,2R,6R)-1,2,6-trihydroxy-5-oxocyclohex-3-ene-1-carboxylate
Synonyms:  
Standard InCHIKey:  DLBOMVFEFWKKHS-MUZBHQQFSA-N
Standard InCHI:  InChI=1S/C27H28O14/c28-11-18-20(32)21(33)22(41-24(35)13-4-2-1-3-5-13)25(40-18)39-17-8-6-15(29)10-14(17)12-38-26(36)27(37)19(31)9-7-16(30)23(27)34/h1-10,18-23,25,28-29,31-34,37H,11-12H2/t18-,19-,20-,21+,22-,23+,25-,27-/m1/s1
SMILES:  OC[C@H]1O[C@@H](Oc2ccc(cc2COC(=O)[C@@]2(O)[C@H](O)C=CC(=O)[C@@H]2O)O)[C@@H]([C@H]([C@@H]1O)O)OC(=O)c1ccccc1
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL2316620
PubChem CID:   71575417
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0004603] Organic oxygen compounds
      • [CHEMONTID:0000323] Organooxygen compounds
        • [CHEMONTID:0000011] Carbohydrates and carbohydrate conjugates
          • [CHEMONTID:0002105] Glycosyl compounds
            • [CHEMONTID:0004165] Phenolic glycosides

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO22355 Flacourtia indica Species Salicaceae Eukaryota n.a. n.a. n.a. PMID[23354072]
NPO22355 Flacourtia indica Species Salicaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT189 Cell Line Vero Chlorocebus aethiops CC50 = 77300.0 nM PMID[543072]
NPT475 Organism Plasmodium yoelii Plasmodium yoelii IC50 > 50000.0 nM PMID[543072]
NPT485 Organism Plasmodium falciparum (isolate K1 / Thailand) Plasmodium falciparum K1 IC50 > 5000.0 nM PMID[543072]
NPT2 Others Unspecified Ratio CC50/IC50 = 17.6 n.a. PMID[543072]
NPT6 Organism Plasmodium falciparum Plasmodium falciparum IC50 = 4400.0 nM PMID[543072]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC57072 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC231475
0.9801 High Similarity NPC474398
0.9801 High Similarity NPC474441
0.9801 High Similarity NPC474401
0.9801 High Similarity NPC476026
0.9677 High Similarity NPC280923
0.9487 High Similarity NPC475183
0.9434 High Similarity NPC280385
0.9404 High Similarity NPC131874
0.94 High Similarity NPC22137
0.9367 High Similarity NPC475174
0.9359 High Similarity NPC71780
0.9346 High Similarity NPC230439
0.9346 High Similarity NPC299761
0.9346 High Similarity NPC279281
0.9346 High Similarity NPC92153
0.9333 High Similarity NPC140722
0.9333 High Similarity NPC92054
0.9333 High Similarity NPC4958
0.9281 High Similarity NPC215811
0.9276 High Similarity NPC93619
0.9205 High Similarity NPC83975
0.9198 High Similarity NPC470438
0.9156 High Similarity NPC183536
0.9156 High Similarity NPC34965
0.9139 High Similarity NPC474422
0.9097 High Similarity NPC260604
0.9097 High Similarity NPC299435
0.8994 High Similarity NPC132737
0.8933 High Similarity NPC245219
0.8933 High Similarity NPC31081
0.8933 High Similarity NPC65833
0.8882 High Similarity NPC127415
0.8875 High Similarity NPC217950
0.8854 High Similarity NPC185103
0.8831 High Similarity NPC302989
0.8827 High Similarity NPC178281
0.8805 High Similarity NPC177742
0.8795 High Similarity NPC237435
0.8795 High Similarity NPC115760
0.8795 High Similarity NPC101191
0.8795 High Similarity NPC210094
0.8795 High Similarity NPC43211
0.8795 High Similarity NPC477848
0.8795 High Similarity NPC49344
0.8795 High Similarity NPC264735
0.8795 High Similarity NPC135277
0.8758 High Similarity NPC282169
0.8743 High Similarity NPC198324
0.8743 High Similarity NPC233994
0.8743 High Similarity NPC211532
0.8743 High Similarity NPC472380
0.8743 High Similarity NPC472384
0.8743 High Similarity NPC472385
0.8743 High Similarity NPC268533
0.8743 High Similarity NPC472382
0.8734 High Similarity NPC470331
0.8727 High Similarity NPC235260
0.8727 High Similarity NPC20505
0.8727 High Similarity NPC245014
0.8727 High Similarity NPC84265
0.8727 High Similarity NPC155763
0.8727 High Similarity NPC282987
0.8718 High Similarity NPC471214
0.8704 High Similarity NPC101116
0.8704 High Similarity NPC27942
0.8704 High Similarity NPC212099
0.8704 High Similarity NPC278329
0.8704 High Similarity NPC146837
0.8696 High Similarity NPC328093
0.8688 High Similarity NPC223335
0.8688 High Similarity NPC40920
0.8684 High Similarity NPC145319
0.8675 High Similarity NPC254540
0.8675 High Similarity NPC172807
0.8675 High Similarity NPC117260
0.8675 High Similarity NPC175107
0.8675 High Similarity NPC476405
0.8675 High Similarity NPC211594
0.8675 High Similarity NPC190003
0.8675 High Similarity NPC472386
0.8667 High Similarity NPC246274
0.8667 High Similarity NPC138927
0.8662 High Similarity NPC475890
0.865 High Similarity NPC121703
0.865 High Similarity NPC80068
0.8647 High Similarity NPC36138
0.8642 High Similarity NPC48093
0.8642 High Similarity NPC129217
0.8642 High Similarity NPC259957
0.8642 High Similarity NPC216496
0.8642 High Similarity NPC224530
0.8642 High Similarity NPC85707
0.8642 High Similarity NPC159579
0.8634 High Similarity NPC469654
0.8634 High Similarity NPC74319
0.8634 High Similarity NPC287872
0.8631 High Similarity NPC144097
0.8631 High Similarity NPC472991
0.8631 High Similarity NPC472992
0.8631 High Similarity NPC61904
0.8627 High Similarity NPC242756
0.8625 High Similarity NPC323593
0.8625 High Similarity NPC261866
0.8625 High Similarity NPC307938
0.8625 High Similarity NPC203500
0.8623 High Similarity NPC45522
0.8623 High Similarity NPC4390
0.8623 High Similarity NPC21666
0.8623 High Similarity NPC42773
0.8623 High Similarity NPC101026
0.8623 High Similarity NPC169977
0.8623 High Similarity NPC24043
0.8614 High Similarity NPC149011
0.8614 High Similarity NPC44558
0.8614 High Similarity NPC105511
0.8614 High Similarity NPC244776
0.8614 High Similarity NPC210808
0.8614 High Similarity NPC199079
0.8614 High Similarity NPC471416
0.8614 High Similarity NPC116864
0.8614 High Similarity NPC34287
0.8614 High Similarity NPC204937
0.8606 High Similarity NPC45618
0.8606 High Similarity NPC146792
0.8606 High Similarity NPC63470
0.8606 High Similarity NPC58716
0.8606 High Similarity NPC116745
0.8599 High Similarity NPC182350
0.8598 High Similarity NPC139060
0.8598 High Similarity NPC85751
0.8598 High Similarity NPC129264
0.8598 High Similarity NPC72016
0.8598 High Similarity NPC19240
0.8598 High Similarity NPC205824
0.8598 High Similarity NPC277205
0.8596 High Similarity NPC470416
0.8589 High Similarity NPC4013
0.8589 High Similarity NPC90905
0.8589 High Similarity NPC61594
0.8589 High Similarity NPC22324
0.8589 High Similarity NPC56735
0.8588 High Similarity NPC222674
0.858 High Similarity NPC253521
0.858 High Similarity NPC476619
0.858 High Similarity NPC35167
0.858 High Similarity NPC113836
0.858 High Similarity NPC472387
0.858 High Similarity NPC37668
0.858 High Similarity NPC476622
0.858 High Similarity NPC476621
0.858 High Similarity NPC44507
0.858 High Similarity NPC476623
0.858 High Similarity NPC476620
0.858 High Similarity NPC476618
0.8571 High Similarity NPC197896
0.8571 High Similarity NPC54802
0.8571 High Similarity NPC108831
0.8571 High Similarity NPC135391
0.8571 High Similarity NPC156457
0.8571 High Similarity NPC223426
0.8571 High Similarity NPC34267
0.8571 High Similarity NPC313163
0.8571 High Similarity NPC161749
0.8571 High Similarity NPC258035
0.8571 High Similarity NPC253685
0.8571 High Similarity NPC78263
0.8571 High Similarity NPC214621
0.8571 High Similarity NPC6985
0.8571 High Similarity NPC182634
0.8571 High Similarity NPC133671
0.8571 High Similarity NPC197304
0.8571 High Similarity NPC60966
0.8571 High Similarity NPC77672
0.8571 High Similarity NPC81042
0.8571 High Similarity NPC43638
0.8563 High Similarity NPC205076
0.8563 High Similarity NPC257011
0.8563 High Similarity NPC137871
0.8563 High Similarity NPC307518
0.8563 High Similarity NPC48773
0.8563 High Similarity NPC153755
0.8563 High Similarity NPC288152
0.8563 High Similarity NPC9002
0.8563 High Similarity NPC315619
0.8562 High Similarity NPC237560
0.8562 High Similarity NPC164599
0.8562 High Similarity NPC10205
0.8554 High Similarity NPC112755
0.8554 High Similarity NPC58053
0.8554 High Similarity NPC105025
0.8554 High Similarity NPC226294
0.8554 High Similarity NPC201292
0.8554 High Similarity NPC472133
0.8554 High Similarity NPC170675
0.8554 High Similarity NPC222455
0.8554 High Similarity NPC475942
0.8554 High Similarity NPC186807
0.8554 High Similarity NPC472383
0.8554 High Similarity NPC93337

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC57072 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8797 High Similarity NPD5402 Approved
0.8795 High Similarity NPD4338 Clinical (unspecified phase)
0.8571 High Similarity NPD4381 Clinical (unspecified phase)
0.8497 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.8354 Intermediate Similarity NPD5403 Approved
0.8343 Intermediate Similarity NPD6797 Phase 2
0.8304 Intermediate Similarity NPD8312 Approved
0.8304 Intermediate Similarity NPD8313 Approved
0.8294 Intermediate Similarity NPD7251 Discontinued
0.8274 Intermediate Similarity NPD3818 Discontinued
0.8274 Intermediate Similarity NPD3751 Discontinued
0.8246 Intermediate Similarity NPD7808 Phase 3
0.8228 Intermediate Similarity NPD5401 Approved
0.8225 Intermediate Similarity NPD7054 Approved
0.8225 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.8187 Intermediate Similarity NPD6559 Discontinued
0.8176 Intermediate Similarity NPD7074 Phase 3
0.8176 Intermediate Similarity NPD7472 Approved
0.8121 Intermediate Similarity NPD7075 Discontinued
0.8061 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.8033 Intermediate Similarity NPD7435 Discontinued
0.7975 Intermediate Similarity NPD4380 Phase 2
0.7967 Intermediate Similarity NPD6777 Approved
0.7967 Intermediate Similarity NPD6782 Approved
0.7967 Intermediate Similarity NPD6776 Approved
0.7967 Intermediate Similarity NPD6780 Approved
0.7967 Intermediate Similarity NPD6778 Approved
0.7967 Intermediate Similarity NPD6781 Approved
0.7967 Intermediate Similarity NPD6779 Approved
0.7963 Intermediate Similarity NPD1653 Approved
0.7941 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.7941 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.7941 Intermediate Similarity NPD6166 Phase 2
0.7939 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.7929 Intermediate Similarity NPD3787 Discontinued
0.7919 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7892 Intermediate Similarity NPD3817 Phase 2
0.7879 Intermediate Similarity NPD6801 Discontinued
0.7862 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7831 Intermediate Similarity NPD2801 Approved
0.7826 Intermediate Similarity NPD6799 Approved
0.7778 Intermediate Similarity NPD7874 Approved
0.7778 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.7771 Intermediate Similarity NPD1934 Approved
0.7771 Intermediate Similarity NPD7685 Pre-registration
0.7742 Intermediate Similarity NPD7697 Approved
0.7742 Intermediate Similarity NPD7696 Phase 3
0.7742 Intermediate Similarity NPD7698 Approved
0.7738 Intermediate Similarity NPD3882 Suspended
0.7725 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.7725 Intermediate Similarity NPD8455 Phase 2
0.7722 Intermediate Similarity NPD2935 Discontinued
0.7722 Intermediate Similarity NPD1551 Phase 2
0.7702 Intermediate Similarity NPD6190 Approved
0.7701 Intermediate Similarity NPD7870 Phase 2
0.7701 Intermediate Similarity NPD7871 Phase 2
0.7692 Intermediate Similarity NPD1933 Approved
0.7692 Intermediate Similarity NPD6534 Approved
0.7692 Intermediate Similarity NPD6535 Approved
0.7672 Intermediate Similarity NPD7701 Phase 2
0.7667 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7654 Intermediate Similarity NPD8150 Discontinued
0.7654 Intermediate Similarity NPD8434 Phase 2
0.764 Intermediate Similarity NPD3750 Approved
0.7632 Intermediate Similarity NPD1203 Approved
0.7625 Intermediate Similarity NPD1549 Phase 2
0.7622 Intermediate Similarity NPD1512 Approved
0.7619 Intermediate Similarity NPD7819 Suspended
0.7605 Intermediate Similarity NPD7411 Suspended
0.76 Intermediate Similarity NPD5844 Phase 1
0.76 Intermediate Similarity NPD1091 Approved
0.7598 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7594 Intermediate Similarity NPD6823 Phase 2
0.759 Intermediate Similarity NPD3226 Approved
0.758 Intermediate Similarity NPD447 Suspended
0.7568 Intermediate Similarity NPD7700 Phase 2
0.7568 Intermediate Similarity NPD7699 Phase 2
0.7562 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.7562 Intermediate Similarity NPD7266 Discontinued
0.7562 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.7561 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.7552 Intermediate Similarity NPD7801 Approved
0.7545 Intermediate Similarity NPD6599 Discontinued
0.7531 Intermediate Similarity NPD4628 Phase 3
0.75 Intermediate Similarity NPD1511 Approved
0.75 Intermediate Similarity NPD2313 Discontinued
0.75 Intermediate Similarity NPD5494 Approved
0.7485 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7484 Intermediate Similarity NPD6832 Phase 2
0.7468 Intermediate Similarity NPD1899 Clinical (unspecified phase)
0.7461 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.7461 Intermediate Similarity NPD7783 Phase 2
0.7456 Intermediate Similarity NPD6844 Discontinued
0.7455 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7453 Intermediate Similarity NPD2346 Discontinued
0.7452 Intermediate Similarity NPD6233 Phase 2
0.7421 Intermediate Similarity NPD8320 Phase 1
0.7421 Intermediate Similarity NPD8319 Approved
0.7412 Intermediate Similarity NPD1465 Phase 2
0.7387 Intermediate Similarity NPD8155 Clinical (unspecified phase)
0.7384 Intermediate Similarity NPD3749 Approved
0.7368 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.7362 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7351 Intermediate Similarity NPD6212 Phase 3
0.7351 Intermediate Similarity NPD6214 Clinical (unspecified phase)
0.7351 Intermediate Similarity NPD6213 Phase 3
0.7349 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.7345 Intermediate Similarity NPD7228 Approved
0.733 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7329 Intermediate Similarity NPD1510 Phase 2
0.7329 Intermediate Similarity NPD3748 Approved
0.7329 Intermediate Similarity NPD7033 Discontinued
0.7326 Intermediate Similarity NPD7768 Phase 2
0.732 Intermediate Similarity NPD9717 Approved
0.7317 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7314 Intermediate Similarity NPD6232 Discontinued
0.7288 Intermediate Similarity NPD7473 Discontinued
0.7284 Intermediate Similarity NPD2796 Approved
0.7278 Intermediate Similarity NPD6798 Discontinued
0.7268 Intermediate Similarity NPD8151 Discontinued
0.7262 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7257 Intermediate Similarity NPD6959 Discontinued
0.7255 Intermediate Similarity NPD1547 Clinical (unspecified phase)
0.7251 Intermediate Similarity NPD37 Approved
0.7241 Intermediate Similarity NPD6234 Discontinued
0.7226 Intermediate Similarity NPD3225 Approved
0.7225 Intermediate Similarity NPD4966 Approved
0.7225 Intermediate Similarity NPD4965 Approved
0.7225 Intermediate Similarity NPD4967 Phase 2
0.7222 Intermediate Similarity NPD2799 Discontinued
0.7222 Intermediate Similarity NPD4308 Phase 3
0.7186 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7176 Intermediate Similarity NPD7458 Discontinued
0.7175 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.717 Intermediate Similarity NPD411 Approved
0.7165 Intermediate Similarity NPD7584 Approved
0.716 Intermediate Similarity NPD7097 Phase 1
0.7159 Intermediate Similarity NPD7199 Phase 2
0.7143 Intermediate Similarity NPD6355 Discontinued
0.7135 Intermediate Similarity NPD7784 Clinical (unspecified phase)
0.7134 Intermediate Similarity NPD2798 Approved
0.7113 Intermediate Similarity NPD7211 Clinical (unspecified phase)
0.7091 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7081 Intermediate Similarity NPD1613 Approved
0.7081 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7081 Intermediate Similarity NPD1240 Approved
0.707 Intermediate Similarity NPD2797 Approved
0.7063 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7063 Intermediate Similarity NPD3268 Approved
0.7053 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7041 Intermediate Similarity NPD7585 Approved
0.7037 Intermediate Similarity NPD230 Phase 1
0.7033 Intermediate Similarity NPD5953 Discontinued
0.703 Intermediate Similarity NPD2343 Clinical (unspecified phase)
0.7025 Intermediate Similarity NPD1019 Discontinued
0.6995 Remote Similarity NPD7240 Approved
0.6994 Remote Similarity NPD1607 Approved
0.699 Remote Similarity NPD7583 Approved
0.6983 Remote Similarity NPD3926 Phase 2
0.6981 Remote Similarity NPD2861 Phase 2
0.6975 Remote Similarity NPD4060 Phase 1
0.6975 Remote Similarity NPD4307 Phase 2
0.6974 Remote Similarity NPD9493 Approved
0.6968 Remote Similarity NPD3496 Discontinued
0.6966 Remote Similarity NPD1247 Approved
0.6957 Remote Similarity NPD3764 Approved
0.6951 Remote Similarity NPD4978 Clinical (unspecified phase)
0.6949 Remote Similarity NPD919 Approved
0.6941 Remote Similarity NPD2532 Approved
0.6941 Remote Similarity NPD2533 Approved
0.6941 Remote Similarity NPD2534 Approved
0.6928 Remote Similarity NPD2344 Approved
0.6918 Remote Similarity NPD5647 Approved
0.6914 Remote Similarity NPD4062 Phase 3
0.6901 Remote Similarity NPD5049 Phase 3
0.6901 Remote Similarity NPD6273 Approved
0.6894 Remote Similarity NPD7095 Approved
0.6886 Remote Similarity NPD2424 Discontinued
0.6879 Remote Similarity NPD1481 Phase 2
0.6879 Remote Similarity NPD1608 Approved
0.6875 Remote Similarity NPD8059 Phase 3
0.6875 Remote Similarity NPD8058 Clinical (unspecified phase)
0.6871 Remote Similarity NPD7966 Clinical (unspecified phase)
0.6868 Remote Similarity NPD7799 Discontinued
0.6867 Remote Similarity NPD6032 Approved
0.6867 Remote Similarity NPD6099 Approved
0.6867 Remote Similarity NPD6100 Approved
0.6864 Remote Similarity NPD2354 Approved
0.6864 Remote Similarity NPD3887 Approved
0.686 Remote Similarity NPD920 Approved
0.6855 Remote Similarity NPD1470 Approved
0.6854 Remote Similarity NPD5537 Clinical (unspecified phase)
0.6847 Remote Similarity NPD8404 Phase 2
0.6845 Remote Similarity NPD1652 Phase 2
0.6842 Remote Similarity NPD642 Clinical (unspecified phase)
0.6842 Remote Similarity NPD4662 Approved
0.6842 Remote Similarity NPD4661 Approved
0.6832 Remote Similarity NPD7930 Approved
0.6832 Remote Similarity NPD1529 Clinical (unspecified phase)
0.6831 Remote Similarity NPD8470 Clinical (unspecified phase)

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data